| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Torray Funds | 0.23% | 23,286 | TRIMMED (-8.4%) |
| Oakmark Funds | 0.07% | 766,520 | NEW |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
| Institutions holding | 671 of 8,857 filers |
| Long-only filers among them | 669 |
| Change vs 2026 Q1 | +12 net · 626 entered · 614 exited |
| Shares reported, all filers | 207,672,733 |
| Reported value, all filers | $13.9B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
3 insiders bought on the open market in the last 90 days (5 purchases, $1.9M), against 0 sales by 0 insiders ($0). Latest buy: Sep 16, 2026.
Source: SEC Form 4 filings, as of Oct 3, 2026. Open-market transactions only.
1 House members reported buying (2 purchases vs 0 sales). Bought by Democrats. Latest buy: Jun 5, 2026.
Source: U.S. House Clerk STOCK Act periodic transaction reports, as of Oct 3, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade. Senate reports are not included yet.
Insiders
· Insider Cluster Buying — Last 90 days: 3 or more different insiders bought on the open market
· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions
· Opportunistic Buys (Non-Routine) — Last 90 days: 2 or more insiders with no routine buying pattern bought on the open market
Politicians
· Bought by Members — Last 6 months: bought by a U.S. House member
Financial Screens
· Growth — Revenue up every year for 5 straight years
· Graham — Sound finances and a long run of profits
· Piotroski — Financial health improved over the past year
· Dividend Growth — Dividends raised for more than 10 years
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
Key figures
· Growth — Latest revenue: $2.1B · 5-yr revenue CAGR: 8.2% · Straight growth years: 9
· Graham — Current ratio: 1.89 · Straight profitable years: 18 · Debt ratio: 0.50 · Latest net income: $374.9M
· Piotroski — F-score: 8 · Return on assets: 7.7% · Operating cash flow: $593.6M
· Dividend Growth — Dividend per share: 0.03 · Dividend yield: 0.1% · Straight dividend years: 12 · 10-yr dividend growth: 0.0%
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 2.00 · Operating cash flow: $796.1M · Net income: $374.9M
· Insider Cluster Buying — Insiders buying: 3 · Buy txns: 5 · Buy value: $1.9M · Latest buy: Sep 16, 2026
· Insider Net Buying — Buy txns: 5 · Sell txns: 0 · Buy value: $1.9M · Latest buy: Sep 16, 2026
· Opportunistic Buys (Non-Routine) — Opportunistic buyers: 3 · Buy txns: 5 · Buy value: $1.9M · Latest buy: Sep 16, 2026
· Bought by Members — Members buying: 1 · Buy txns: 2 · Sell txns: 0 · Latest buy: Jun 5, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2025 Q4, ranked #10 of 50.
· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2026 Q2, ranked #47 of 50.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.